TY - JOUR
T1 - The critical role of BTRC in hepatic steatosis as an ATGL E3 ligase
AU - Qi, Weiwei
AU - Fang, Zhenzhen
AU - Luo, Chuanghua
AU - Hong, Honghai
AU - Long, Yanlan
AU - Dai, Zhiyu
AU - Liu, Junxi
AU - Zeng, Yongcheng
AU - Zhou, Ti
AU - Xia, Yong
AU - Yang, Xia
AU - Gao, Guoquan
N1 - Publisher Copyright:
© The Author(s) (2023). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, CEMCS, CAS.
PY - 2023/10/1
Y1 - 2023/10/1
N2 - Non-alcoholic fatty liver disease (NAFLD), characterized by hepatic steatosis, is one of the commonest causes of liver dysfunction. Adipose triglyceride lipase (ATGL) is closely related to lipid turnover and hepatic steatosis as the speed-limited triacylglycerol lipase in liver lipolysis. However, the expression and regulation of ATGL in NAFLD remain unclear. Herein, our results showed that ATGL protein levels were decreased in the liver tissues of high-fat diet (HFD)-fed mice, naturally obese mice, and cholangioma/hepatic carcinoma patients with hepatic steatosis, as well as in the oleic acid-induced hepatic steatosis cell model, while ATGL mRNA levels were not changed. ATGL protein was mainly degraded through the proteasome pathway in hepatocytes. Beta-transducin repeat containing (BTRC) was upregulated and negatively correlated with the decreased ATGL level in these hepatic steatosis models. Consequently, BTRC was identified as the E3 ligase for ATGL through predominant ubiquitination at the lysine 135 residue. Moreover, adenovirus-mediated knockdown of BTRC ameliorated steatosis in HFD-fed mouse livers and oleic acid-treated liver cells via upregulating the ATGL level. Taken together, BTRC plays a crucial role in hepatic steatosis as a new ATGL E3 ligase and may serve as a potential therapeutic target for treating NAFLD.
AB - Non-alcoholic fatty liver disease (NAFLD), characterized by hepatic steatosis, is one of the commonest causes of liver dysfunction. Adipose triglyceride lipase (ATGL) is closely related to lipid turnover and hepatic steatosis as the speed-limited triacylglycerol lipase in liver lipolysis. However, the expression and regulation of ATGL in NAFLD remain unclear. Herein, our results showed that ATGL protein levels were decreased in the liver tissues of high-fat diet (HFD)-fed mice, naturally obese mice, and cholangioma/hepatic carcinoma patients with hepatic steatosis, as well as in the oleic acid-induced hepatic steatosis cell model, while ATGL mRNA levels were not changed. ATGL protein was mainly degraded through the proteasome pathway in hepatocytes. Beta-transducin repeat containing (BTRC) was upregulated and negatively correlated with the decreased ATGL level in these hepatic steatosis models. Consequently, BTRC was identified as the E3 ligase for ATGL through predominant ubiquitination at the lysine 135 residue. Moreover, adenovirus-mediated knockdown of BTRC ameliorated steatosis in HFD-fed mouse livers and oleic acid-treated liver cells via upregulating the ATGL level. Taken together, BTRC plays a crucial role in hepatic steatosis as a new ATGL E3 ligase and may serve as a potential therapeutic target for treating NAFLD.
KW - adipose triglyceride lipase (ATGL)
KW - beta-transducin repeat containing (BTRC)
KW - non-alcoholic fatty liver disease (NAFLD)
KW - obesity
KW - proteasomal degradation
UR - http://www.scopus.com/inward/record.url?scp=85179043386&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85179043386&partnerID=8YFLogxK
U2 - 10.1093/jmcb/mjad064
DO - 10.1093/jmcb/mjad064
M3 - Article
C2 - 37873692
AN - SCOPUS:85179043386
SN - 1674-2788
VL - 15
JO - Journal of Molecular Cell Biology
JF - Journal of Molecular Cell Biology
IS - 10
M1 - mjad064
ER -